Estimated antiretroviral therapy coverage among people living with HIV in Chile
Chile: Estimated antiretroviral therapy coverage among people living with HIV was 73.0% in 2025. ▲ Rising
Estimated antiretroviral therapy coverage among people living with HIV in Chile, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among people living with hiv in Chile is 73.0%, measured in 2025.
That represents a change of up 30.4% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Chile peaked at 77.0% in 2022 and was at its lowest, 11.0%, in 2000.
That places Chile 75th out of 143 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Estimated antiretroviral therapy coverage among people living with HIV in Chile, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 11.0% | — |
| 2001 | 14.0% | +27.3% |
| 2002 | 19.0% | +35.7% |
| 2003 | 23.0% | +21.1% |
| 2004 | 24.0% | +4.3% |
| 2005 | 33.0% | +37.5% |
| 2006 | 32.0% | -3.0% |
| 2007 | 33.0% | +3.1% |
| 2008 | 34.0% | +3.0% |
| 2009 | 37.0% | +8.8% |
| 2010 | 38.0% | +2.7% |
| 2011 | 39.0% | +2.6% |
| 2012 | 45.0% | +15.4% |
| 2013 | 49.0% | +8.9% |
| 2014 | 53.0% | +8.2% |
| 2015 | 56.0% | +5.7% |
| 2016 | 61.0% | +8.9% |
| 2017 | 68.0% | +11.5% |
| 2018 | 73.0% | +7.4% |
| 2019 | 76.0% | +4.1% |
| 2020 | 76.0% | +0.0% |
| 2021 | 76.0% | +0.0% |
| 2022 | 77.0% | +1.3% |
| 2023 | 76.0% | -1.3% |
| 2024 | 73.0% | -3.9% |
| 2025 | 73.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 26.0% | 11.0% | 37.0% | 10 |
| 2010s | 55.8% | 38.0% | 76.0% | 10 |
| 2020s | 75.2% | 73.0% | 77.0% | 6 |
Countries ranked near Chile
More health data for Chile
- Un projection of annual infant deaths, annual growth rate -1.71 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4062 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,755 deaths per 1,000 people (2090)
- Number of infants who die before age 1 115 deaths (2100)
- Population ages 30-34, female, annual growth rate -0.0729 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0411 units per person (2025)
- Population ages 30-34, male, annual growth rate -0.2141 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.042 units per person (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Chile?
- Estimated antiretroviral therapy coverage among people living with hiv in Chile was 73.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Chile?
- The highest recorded value was 77.0% in 2022.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Chile?
- The lowest recorded value was 11.0% in 2000.
- How does Chile rank for estimated antiretroviral therapy coverage among people living with hiv?
- Chile ranks 75th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Chile?
- Over the last ten years it is up 30.4%. The long-run trend across the full record is rising.
- Where does this Chile data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).